- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Entod Pharma appoints Prof Vivek Padgaonkar as Non-Executive Independent Director
New Delhi: ENTOD Pharmaceuticals has appointed Prof. Vivek Padgaonkar, former Director of the OPPI (Project & Policy), as a non-executive independent director.
Prof. Padgaonkar brings a wealth of experience from his extensive work with various lobbying and think-tank organisations on healthcare issues. His collaborations with several government ministries have significantly shaped current pharmaceutical policies. He also holds independent directorships at Martin & Harris Labs Ltd., Bervin Investment & Leasing Limited, and Juvenor Healthcare.
Founded in 1977, ENTOD Pharmaceuticals is a research-driven Indian pharmaceutical company. The company operates in more than 67 countries.
Dr. Vivek Padgaonkar expressed his eagerness about joining the board, "I am honoured to join ENTOD Pharmaceuticals and contribute to its mission of driving innovation in the pharmaceutical industry. This is a remarkable opportunity to leverage my experience with a company at the forefront of technological advancements."
Nikkhil K. Masurkar, CEO of ENTOD Pharmaceuticals, commented on the appointment, "We are thrilled to welcome Prof. Padgaonkar to our board. His extensive experience and respected stature in the industry will be invaluable as we strive to position ENTOD and the Indian pharmaceutical sector as global leaders in innovation. His insights will be crucial in our ongoing efforts to develop novel solutions using advanced AI technologies, pushing our vision of a future-ready pharmaceutical industry."
Earlier this year, ENTOD Pharmaceuticals inaugurated its state-of-the-art research & development centre. The DSIR-approved research laboratory is equipped with the latest molecular and formulation research tools, microbiology testing facilities, sterile batch production capacity, and high-end quality assurance/quality control analytical equipment.
entod pharmaentod pharma newsappointmentProf Vivek PadgaonkarOPPIMartin & Harris LabsBervin Investment & LeasingJuvenor Healthcare
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story